Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling-Reference-Cited by-同舟云学术

Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling

Published:2016-08-16 Issue:6 Volume:115 Page:691-702
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Baker Lauren CJ,Boult Jessica KR,Thomas Markus,Koehler Astrid,Nayak Tapan,Tessier Jean,Ooi Chia-Huey,Birzele Fabian,Belousov Anton,Zajac Magdalena,Horn Carsten,LeFave Clare,Robinson Simon P

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016236.pdf

Reference52 articles.

1. Baker LC, Boult JK, Walker-Samuel S, Chung YL, Jamin Y, Ashcroft M, Robinson SP (2012) The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function. Br J Cancer 106: 1638–1647.

2. Bashir MR, Bhatti L, Marin D, Nelson RC (2015) Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 41: 884–898.

3. Batchelor T, Sorensen A, di Tomaso E, Zhang W, Duda D, Cohen K, Kozak K, Cahill D, Chen P, Zhu M, Ancukiewicz M, Mrugala M, Plotkin S, Drappatz J, Louis D, Ivy P, Scadden D, Benner T, Loeffler J, Wen P, Jain R (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11: 83–95.

4. Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8: 592–603.

5. Bessho H, Wong B, Huang D, Tan J, Ong CK, Iwamura M, Hart S, Dangl M, Thomas M, Teh BT (2015) Effect of Ang-2-VEGF-A bispecific antibody in renal cell carcinoma. Cancer Invest 33: 378–386.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes;Ultrasound in Medicine & Biology;2024-04

2. Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling;Molecules;2021-11-13

3. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy;Science Translational Medicine;2021-07-28

4. Ten years in the making: application of CrossMab technology for the development of therapeutic bispecific antibodies and antibody fusion proteins;mAbs;2021-01-01

5. Development and clinical application of bispecific antibody in the treatment of colorectal cancer;Expert Review of Clinical Immunology;2020-07-02